| Trial Identifier: | 215360 |
| Sponsor: | GlaxoSmithKline |
| Collaborator: |
NA
|
| Start Date: | July 2022 |
| Primary Completion Date: | October 2025 |
| Study Completion Date: | October 2025 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Country | Location |
|---|---|
| ARGENTINA | Buenos Aires, ARGENTINA, 1888 |
| ARGENTINA | Buenos Aires, ARGENTINA, C1028AAP |
| ARGENTINA | Quilmes, ARGENTINA, 1878 |
| BRAZIL | SAO PAULO, BRAZIL, 05410-002 |
| BRAZIL | Sorocaba, BRAZIL, 18040-425 |
| ISRAEL | PETACH TIKVA, ISRAEL, 49202 |
| NETHERLANDS | ROTTERDAM, NETHERLANDS, 3015 CE |
| TURKEY | Ankara, TURKEY, 6230 |
| TURKEY | Izmir, TURKEY, 35100 |
| TURKEY | Kayseri, TURKEY, 38039 |
| UNITED_STATES, MN | Rochester, MN, UNITED_STATES, 55905 |
| UNITED_STATES, OH | Cincinatti, OH, UNITED_STATES, 45229 |
| UNITED_STATES, OH | Cleveland, OH, UNITED_STATES, 44106 |
| UNITED_STATES, SC | Charleston, SC, UNITED_STATES, 29425 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2026 Pharma Intelligence UK Limited (Citeline), a Norstella company